Abortion providers rush to make backup plans as Supreme Court decides whether to keep limits on mifepristone

[ad_1] U.S. abortion pill providers are scrambling to make backup plans as the Supreme Court decides whether to keep restrictions on the key drug mifepristone.  Some in-person clinics in New York, California and Kansas will offer mifepristone for now, but are preparing to provide an alternative abortion pill if a subsequent decision essentially bans the…

Read More

Blocking FDA approval of abortion pill could stifle innovation in the biopharma industry, experts say

[ad_1] A messy legal fight over the Food and Drug Administration’s approval of the abortion pill mifepristone poses risks to the biopharma industry that go beyond the single drug. If a subsequent decision tosses out the pill’s approval, it could potentially stifle innovation in the sector and deter investments in the development of life-changing drugs,…

Read More